Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Oraianthi Fiste
Observed names:
O Fiste,
O. Fiste
Institutions:
National and Kapodistrian University of Athens,
Alexandra Hospital,
Hellenic Oncology Research Group,
Sotiria General Hospital
Observed institutions:
National and Kapodistrian University of Athens,
401 General Military Hospital of Athens,
Alexandra Hospital,
Hellenic Oncology Research Group,
Sotiria General Hospital
ORCID:
0000-0002-7106-4162
Observed ORCID:
0000-0002-7106-4162
OpenAlex ID:
A5069801632
Circulating tumor cells count as a predictor of survival in lung cancer
2018
·
Konstantinos Syrigos
, Oraianthi Fiste
, et al.
·
Critical Reviews in Oncology/Hematology
·
58
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
2021
·
M. Liontos
, A. Andrikopoulou
, et al.
·
Journal of Ovarian Research
·
47
PDF
Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses
2021
·
Rebecca Georgakopoulou
, Oraianthi Fiste
, et al.
·
Journal of Clinical Medicine
·
42
PDF
Artificial Intelligence-Based Treatment Decisions: A New Era for NSCLC
2024
·
Oraianthi Fiste
, Ioannis Gkiozos
, et al.
·
Cancers
·
41
PDF
The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
2021
·
Oraianthi Fiste
, Ioannis Ntanasis-Stathopoulos
, et al.
·
Vaccines
·
28
PDF
Efficacy of NSCLC Rechallenge with Immune Checkpoint Inhibitors following Disease Progression or Relapse
2024
·
Maria Effrosyni Livanou
, Vasiliki Nikolaidou
, et al.
·
Cancers
·
24
PDF
Machine learning applications in gynecological cancer: A critical review
2022
·
Oraianthi Fiste
, Michalis Liontos
, et al.
·
Critical Reviews in Oncology/Hematology
·
22
Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
2021
·
Maria A. Papadaki
, Ippokratis Messaritakis
, et al.
·
International Journal of Molecular Sciences
·
22
PDF
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
2021
·
Flora Zagouri
, Evangelos Terpos
, et al.
·
The Breast
·
21
Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review
2021
·
Angeliki Andrikopoulou
, Oraianthi Fiste
, et al.
·
Cancers
·
21
PDF
Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance
2021
·
Rebecca Georgakopoulou
, Angeliki Andrikopoulou
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
21
Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials
2024
·
Kleoniki Apostolidou
, Eleni Zografos
, et al.
·
The Breast
·
20
Pembrolizumab in endometrial cancer: Where we stand now (Review)
2021
·
Aikaterini Aravantinou‑Fatorou
, Angeliki Andrikopoulou
, et al.
·
Oncology Letters
·
20
PDF
Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review
2020
·
Oraianthi Fiste
, Michael Liontos
, et al.
·
Annals of Translational Medicine
·
16
PDF
AΙ-Driven Drug Repurposing: Applications and Challenges
2025
·
Paraskevi Keramida
, Nikolaos K. Syrigos
, et al.
·
Medicines
·
14
PDF
Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
2021
·
Michalis Liontos
, Evangelos Terpos
, et al.
·
Vaccines
·
14
PDF
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
2021
·
Michalis Liontos
, Evangelos Terpos
, et al.
·
Prostate Cancer and Prostatic Diseases
·
12
PDF
Cardiovascular complications of ribociclib in breast cancer patients
2024
·
Oraianthi Fiste
, Evangelos Mavrothalassitis
, et al.
·
Critical Reviews in Oncology/Hematology
·
11
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
2023
·
Angeliki Andrikopoulou
, Michalis Liontos
, et al.
·
Cancers
·
9
PDF
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition
2022
·
Evangelos Terpos
, Michalis Liontos
, et al.
·
Cancers
·
9
PDF
Inflammation-related biomarkers as predictors of pathological complete response in early-stage breast cancer
2024
·
Oraianthi Fiste
, Evangelos Mavrothalassitis
, et al.
·
Clinical & Translational Oncology
·
7
CDK4/6 inhibitors and cardiovascular toxicity: Real-world evidence.
2023
·
Oraianthi Fiste
, Michael Liontos
, et al.
·
Journal of Clinical Oncology
·
7
Advances in Gynecological Cancers
2022
·
Michalis Liontos
, Oraianthi Fiste
, et al.
·
International Journal of Molecular Sciences
·
7
PDF
BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients
2021
·
Michalis Liontos
, Eleni Zografos
, et al.
·
Current Oncology
·
7
PDF
Subarachnoid hemorrhage in a postpartum mother: A rare manifestation of an uncommon disease
2022
·
Oraianthi Fiste
, Evaggelos Mavrothalassitis
, et al.
·
Gynecologic Oncology Reports
·
6
PDF
Show more works
View as search
Works count:
49
Citation count:
561
H-index:
14
I10-index:
18
Year
Topic
Type